Pioneering Research

Developing therapeutic and diagnostic products for neurological disorders and orphan indications.

Learn More

Pioneering Research

Developing therapeutic and diagnostic products for neurological disorders and orphan indications.

Learn More

Pioneering Research

Developing therapeutic and diagnostic products for neurological disorders and orphan indications.

Learn More

Therapeutics Pipeline

Amarantus specializes in the identification and acquisition of undervalued assets that have the potential to address huge unmet medical needs. We are dedicated to building and developing a robust pipeline of therapeutic candidates in neurology and ophthalmology diseases and regenerative medicine.

View Pipeline
Phase Preclinical Phase 1 Phase 2 Phase 3 Market
Eltoprazine Parkinson's PD-LID
Preclinical Phase completed
Phase 1 Phase completed
Phase 2 Phase in progress
Phase 3 Phase not started
Market Phase not started
Eltoprazine Adult ADHD
Preclinical Phase completed
Phase 1 Phase completed
Phase 2 Phase in progress
Phase 3 Phase not started
Market Phase not started
Eltoprazine Alzheimer's Aggression
Preclinical Phase completed
Phase 1 Phase in progress
Phase 2 Phase not started
Phase 3 Phase not started
Market Phase not started
ESS Intractable Severe Burns
Preclinical Phase completed
Phase 1 Phase completed
Phase 2 Phase in progress
Phase 3 Phase not started
Market Phase not started
MANF Retinitis Pigmentosa
Preclinical Phase in progress
Phase 1 Phase not started
Phase 2 Phase not started
Phase 3 Phase not started
Market Phase not started
MANF Parkinson's Disease
Preclinical Phase in progress
Phase 1 Phase not started
Phase 2 Phase not started
Phase 3 Phase not started
Market Phase not started

Source, Develop And Monetize Highly Undervalued Biopharma Assets

3 pillars

Three Pillars of Expected Transformational Growth

Amarantus has a focus on developing certain small molecules, biologics, and biomarkers surrounding intellectual property and proprietary technologies it owns.

Social Media

investor presentation

Investor Presentation

View our latest Corporate Presentation

View Presentation

Stock Info View Investor Relations ›

OTCQX: AMBS
Change
Volume
Market Cap